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Objective: HLA-DRB1*16:35 is a low incidence allele in the HLA-DRB1 locus. The objective of this study is
to report the ethnicity of DRB1*16:35 and its deduced probable HLA associated haplotype in two
Taiwanese unrelated bone marrow hematopoietic stem cell donors and to determine its variation from
DRB1*16:02:01 and DRB1*16:01:01.
Materials and Methods: A sequence-based typing method was employed to conﬁrm the low incidence
allele DRB1*16:35. Polymerase chain reaction was performed to amplify exon 2 and exon 3 of the HLA-A
and HLA-B loci and exon 2 of the HLA-DRB1 locus using group-speciﬁc primer sets. The amplicons were
sequenced employing BigDye Terminator Cycle Sequencing Ready Reaction kits in both directions ac-
cording to the manufacturer's protocols.
Results: The DNA sequence of DRB1*16:35 is identical to DRB1*16:02:01 in exons 2, except for residue
364 where the C of DRB1*16:02:01 is replaced by the T of DRB1*16:35 (codon 93, CGG->TGG). The
nucleotide exchange leads to an amino acid alteration to the protein sequence of DRB1*16:02:01 at
residue 93 where the arginine (R) of DRB1*16:02:01 is changed to the tryptophan (W) of DRB1*16:35. We
deduced the probable HLA haplotype in association with DRB1*16:35 in Taiwanese to be A*11-B*13-
DRB1*16:35.
Conclusion: Information on the deduced probable HLA haplotype in association with the low incidence
DRB1*16:35 allele that we report here is of value for HLA testing laboratories for reference purposes. In
addition, it can be used by stem cell transplantation donor search coordinators to determine a strategy
for ﬁnding compatible donors in unrelated bone marrow donor registries when a patient has this un-
common HLA allele.
Copyright © 2016, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
New human leukocyte antigen (HLA) alleles continue to be
revealed and the recognition of HLA low incidence alleles has
enriched our understanding of the complexity of the HLA system.
The major histocompatibility complex (MHC) in humans consists
of several loci of genes that are located on the short arm of
chromosome 6 at 6p21.3. These loci are classiﬁed into MHC classells Centre, Hualien Tzu Chi
alien, Taiwan. Tel.: þ886
lief Tzu Chi Foundation. PublishedI, II and III regions. The genes encoding the HLA alleles are
located in the MHC class I and II regions. The HLA genes are
characterized by their extreme allelic polymorphism as well as
their variations and diversity in different ethnic groups and racial
populations. HLA molecules have been deﬁnitely deﬁned as
transplant antigens and have a strong relevance to tissue trans-
plantation. Their molecular similarity in donors and recipients is
being considered a predictive factor for graft survival and graft-
versus- host disease. It is imperative to precisely characterize any
unknown and low incidence alleles encountered during routine
HLA typing procedures. To facilitate successful and comprehen-
sive unrelated bone marrow hematopoietic stem cell donor
searches for patients in need of hematopoietic stem cell trans-
plantation, persistent efforts are needed to resolve unidentiﬁed,by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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and donor selection.
The nucleotide sequence of HLA-DRB1*16:35 was ﬁrst sub-
mitted to GeneBank (accession number KP711799) and the
name HLA-DRB1*16:35 was ofﬁcially assigned by the World
Health Organization HLA Nomenclature Committee [1]. How-
ever, there was no indication of its ethnicity and its associated
HLA haplotype in the report. Here we report the Taiwanese
ethnicity of DRB1*16:35 and the deduced probable HLA
haplotype in association with DRB1*16:35 based on the HLA-A,
-B and -DRB1 alleles commonly shared by the HLA typing of our
two donors and a donor (donor ID HG00010094) submitted to
the IMGT database [1].
2. Materials and methods
Peripheral whole blood samples from unrelated bone marrow
hematopoietic stem cell donors with Taiwanese ethnicity were
collected in acid citrate dextrose (ACD) anticoagulant. Formal
written consents were signed by the donors before blood
collection. The ACD whole blood samples were stored at 80ºC
until use. Genomic DNA was extracted using QIAamp DNA Blood
Mini Kits according to the manufacturer's instructions (Qiagen,
Hilden, Germany). The DNA material was subjected to HLA gen-
otyping for the HLA-A, HLA-B and HLA-DRB1 loci using com-
mercial polymerase chain reaction sequencing- based typing kits
(Secore® A/B/DRB1 Locus Sequencing kits, Life Technologies,
Brown Deer, WI, USA). High resolution allelic sequencing was
performed as previously described [2e6]. The two sets of primer
sequences used were: 1. B-CG: M13-BIN1-CGG (sense):
TGTAAAACGACGGCCAGTCGGGGGCGCAGGACCCGG; P30exon 5B
(anti-sense): GCTCCGATGACCACAACTGCT and 2. B-TA: M13-
BIN1-TGA (sense): TGTAAAACGACGGCCAGTGGCGGGGGCGCAG-
GACCTGA; P30exon 5B (anti-sense): GCTCCGATGACCACAACTGCT.
The amplicons were sequenced using a BigDye Terminator Cycle
Sequencing Ready Reaction kit (Applied Biosystems, Foster City,
CA, USA) in both directions.
3. Results
We conﬁrmed that the DNA sequence of DRB1*16:35 is identical
to DRB1*16:02:01 in exon 2, except for residue 364 where the C of
DRB1*16:02:01 is replaced by the T of DRB1*16:35 (codon 93, CGG-Fig. 1. (A) The DNA sequence of DRB1*16:35 is identical to DRB1*16:02:01 in exon 2, except a
(shaded) of DRB1*16:35. DRB1*16:01:01 varies from DRB1*16:35 at residues 286 (T->C) and 36
at codon 93 where the arginine (R) of DRB1*16:02:01 is replaced by the tryptophan (W) (sha
lead to two amino acid differences between DRB1*16:35 and DRB1*16:01:01 (underlined). D>TGG) (Fig. 1A). The nucleotide exchange causes an amino acid
alteration to the protein sequence of DRB1*16:02:01 at residue 93
where the arginine (R) of DRB1*16:02:01 is changed to the tryp-
tophan (W) of DRB1*16:35 (Fig. 1B). The HLA typing of our donors
with DRB1*16:35 is A*02, A*11, B*13, B*15, DRB1*08 and
DRB1*16:35, and, A*11:01, A*24:02, B*40:02, B*13:01, DRB1*14:05
and DRB1*16:35. Together with the HLA typing (A*02, A*11, B*13,
B*46, DRB1*09, and DRB1*16*:35) of the cell (donor ID
HG00010094) submitted to the IMGT database [1], we deduced the
probable HLA haplotype in association with DRB1*16:35 in our
Taiwanese donor as A*11-B*13-DRB1*16:35. In addition, we found
that the DNA sequence of DRB1*16:35 varies from DRB1*16:01:01
at residues 286 (C->T) and 364 (T->C) (Fig. 1A) in exon 2. The
nucleotide variations lead to two amino acid differences between
DRB1*16:35 and DRB1*16:01:01 (Fig. 1B).
4. Discussion
We conﬁrmed the DNA sequence and amino acid sequence of
the HLA allele DRB1*16:35 in this study. DRB1*16:35 was reported
initially to the IMGT [1] without indication of its ethnicity [1]. Here
we report the Taiwanese ethnicity of the DRB1*16:35 -bearing
donor in our unrelated marrow donor registry. We deduced the
probable DRB1*16:35-associated HLA haplotype to be A*11-B*13-
DRB1*16:35, based on the commonly shared HLA typing of three
unrelated individuals carrying DRB1*16:35. Our results also
conﬁrmed that the protein sequence of DRB1*16:35 varies from
DRB1*16:02:01 by one amino acid whereas it varies from
DRB1*16:01:01 by two amino acids. This information is important
for DRB1*16:35 patients when a minor mismatched donor is being
considered as a source of hematopoietic stem cell donation for bone
marrow transplantation.
It is worth mentioning that the most direct and classic method
to determine HLA haplotypes is through family study if test ma-
terials from a number of key family members are available. Alter-
natively, population study may be employed if a signiﬁcant number
of unrelated donors is available [2]. However, the haplotypes
deduced via population investigation are considered as likely or
most probable. In this study, because of the lack of availability of
necessary test materials from the family of the donor with
DRB1*16:35, we opted to determine the haplotype by looking at the
HLA alleles carried in common by unrelated donors bearing the
same allele of interest. By the same token, when determiningt residue 364 (codon 93; underlined), where the C of DRB1*16:02:01 is changed to the T
4 (C->T). (B) The nucleotide exchange of DRB1*16:02:01 causes an amino acid exchange
ded) of DRB1*16:35. The nucleotide variations between DRB1*16:01:01 and DRB1*16:35
ashes indicate nucleotide or amino acid identity with DRB*16*02:01.
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alleles shared in common by unrelated individuals may be
employed to deduce associated probable haplotypes [3e10].
The frequency of DRB1*16:35 in Taiwanese is about 1 in 40,000
according our HLA typing practice. To date, the Allele Frequency Net
Database (http://www.allelefrequencies.net/hla6006a.asp?hla_
locus_type¼Classical#) has yet to show the existence of the allele
in the world population. Therefore, we think the probable
DRB1*16:35-associated HLA haplotype in Taiwanese that we
deduced in this study is highly accountable.
The signiﬁcance of determining the ethnicity of individuals with
DRB1*16:35 and its HLA linked haplotypes is that the information
may be employed in anthropological investigation of races in
addition to allowing search coordinators in unrelated bone marrow
donor registries to allocate appropriate unrelated bone marrow
hematopoietic stem cell donors for their patients. Evolution plays
an essential force in the generation of polymorphism on HLA ge-
notypes in humans. Polymorphism may promote recognition of
variation between an individual and its environmental pathogens
which may then allow the individual to mount an immunological
defense strategy against infection. However, when compatibility
becomes an issue in transplantation, HLA determination for poly-
morphism is essential in order to avoid graft rejection or graft-
versus -host disease after tissue or organ transplantation.
The numbers of known HLA alleles are increasing exponentially
with the recent development of DNA-based molecular typing
technology. The outstanding HLA diversity in ethnic groups is
unique and important. Facilitating an appropriate HLA-matched
unrelated bone marrow stem cell donor for successful stem cell
transplantations relies on the accuracy of HLA typing and the spirit
and strength to resolve unknown, ambiguous and low incidence
genes in the HLA system.
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